These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 18440607)
1. Outcome of surgical intrasellar growth hormone tumor performed by a pituitary specialist surgeon in a developing country. Gondim JA; Ferraz T; Mota I; Studart D; Almeida JP; Gomes E; Schops M Surg Neurol; 2009 Jul; 72(1):15-9; discussion 19. PubMed ID: 18440607 [TBL] [Abstract][Full Text] [Related]
2. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years. Abbassioun K; Amirjamshidi M; Mehrazin A; Khalatbary I; Keynama M; Bokai H; Abdollahi M Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431 [TBL] [Abstract][Full Text] [Related]
3. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center. Gondim JA; Almeida JP; de Albuquerque LA; Gomes E; Schops M; Ferraz T Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132 [TBL] [Abstract][Full Text] [Related]
4. Transsphenoidal surgery for growth hormone-secreting pituitary adenomas in 130 patients. Shirvani M; Motiei-Langroudi R World Neurosurg; 2014 Jan; 81(1):125-30. PubMed ID: 23313263 [TBL] [Abstract][Full Text] [Related]
5. Endoscopic Transsphenoidal Approach for Acromegaly with Remission Rates in 401 Patients: 2010 Consensus Criteria. Anik I; Cabuk B; Gokbel A; Selek A; Cetinarslan B; Anik Y; Ceylan S World Neurosurg; 2017 Dec; 108():278-290. PubMed ID: 28887283 [TBL] [Abstract][Full Text] [Related]
6. Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes. Nishioka H; Fukuhara N; Horiguchi K; Yamada S J Neurosurg; 2014 Sep; 121(3):505-10. PubMed ID: 25014437 [TBL] [Abstract][Full Text] [Related]
7. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria. Hazer DB; Işık S; Berker D; Güler S; Gürlek A; Yücel T; Berker M J Neurosurg; 2013 Dec; 119(6):1467-77. PubMed ID: 24074496 [TBL] [Abstract][Full Text] [Related]
8. Acromegaly surgery in Manchester revisited--the impact of reducing surgeon numbers and the 2010 consensus guidelines for disease remission. Wang YY; Higham C; Kearney T; Davis JR; Trainer P; Gnanalingham KK Clin Endocrinol (Oxf); 2012 Mar; 76(3):399-406. PubMed ID: 21824170 [TBL] [Abstract][Full Text] [Related]
9. Suprasellar pituitary adenomas: a 10-year experience in a single tertiary medical center and a literature review. Zhu J; Wang Z; Zhang Y; Liu J; Li X; Deng K; Lu L; Yao Y Pituitary; 2020 Aug; 23(4):367-380. PubMed ID: 32378170 [TBL] [Abstract][Full Text] [Related]
10. Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas. Campbell PG; Kenning E; Andrews DW; Yadla S; Rosen M; Evans JJ Neurosurg Focus; 2010 Oct; 29(4):E5. PubMed ID: 20887130 [TBL] [Abstract][Full Text] [Related]
11. Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery. Taweesomboonyat C; Oearsakul T World Neurosurg; 2021 Feb; 146():e1360-e1366. PubMed ID: 33309643 [TBL] [Abstract][Full Text] [Related]
13. Fully endoscopic transsphenoidal surgery for functioning pituitary adenomas: a retrospective comparison with traditional transsphenoidal microsurgery in the same institution. D'Haens J; Van Rompaey K; Stadnik T; Haentjens P; Poppe K; Velkeniers B Surg Neurol; 2009 Oct; 72(4):336-40. PubMed ID: 19604551 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of transsphenoidal surgery in achieving biochemical cure of growth hormone-secreting pituitary adenomas among patients with cavernous sinus invasion: a systematic review and meta-analysis. Briceno V; Zaidi HA; Doucette JA; Onomichi KB; Alreshidi A; Mekary RA; Smith TR Neurol Res; 2017 May; 39(5):387-398. PubMed ID: 28301972 [TBL] [Abstract][Full Text] [Related]
15. Reoperation for growth hormone-secreting pituitary adenomas: report on an endonasal endoscopic series with a systematic review and meta-analysis of the literature. Almeida JP; Ruiz-Treviño AS; Liang B; Omay SB; Shetty SR; Chen YN; Anand VK; Grover K; Christos P; Schwartz TH J Neurosurg; 2018 Aug; 129(2):404-416. PubMed ID: 28862548 [TBL] [Abstract][Full Text] [Related]
16. Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission. Starke RM; Raper DM; Payne SC; Vance ML; Oldfield EH; Jane JA J Clin Endocrinol Metab; 2013 Aug; 98(8):3190-8. PubMed ID: 23737543 [TBL] [Abstract][Full Text] [Related]
17. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly. Biermasz NR; van Dulken H; Roelfsema F J Clin Endocrinol Metab; 2000 Dec; 85(12):4596-602. PubMed ID: 11134114 [TBL] [Abstract][Full Text] [Related]
18. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study. Plöckinger U; Quabbe HJ Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331 [TBL] [Abstract][Full Text] [Related]
19. [Outcome of surgical treatment for acromegaly performed by a single neurosurgeon and cumulative meta-analysis]. Boeving A; Borba LA; Rodrigues AM; Orichowski EB; Paz Filho GJ; Santos CM; Boguszewski CL Arq Bras Endocrinol Metabol; 2006 Oct; 50(5):884-92. PubMed ID: 17160212 [TBL] [Abstract][Full Text] [Related]
20. Outcome of Endoscopic Transsphenoidal Surgery for Acromegaly. Kim JH; Hur KY; Lee JH; Lee JH; Se YB; Kim HI; Lee SH; Nam DH; Kim SY; Kim KW; Kong DS; Kim YH World Neurosurg; 2017 Aug; 104():272-278. PubMed ID: 28465267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]